Futura Medical (LON:FUM) Stock Price Down 21.1% – Time to Sell?

Futura Medical plc (LON:FUM)’s stock price fell 21.1% on Monday . The stock traded as low as GBX 0.31 and last traded at GBX 0.35. 3,753,080 shares traded hands during trading, a decline of 63% from the average daily volume of 10,207,083 shares. The stock had previously closed at GBX 0.45.

Futura Medical Stock Down 21.1%

The business has a 50-day moving average price of GBX 0.58 and a 200-day moving average price of GBX 0.99. The firm has a market capitalization of £2.06 million, a P/E ratio of -0.13 and a beta of 0.02.

Futura Medical (LON:FUM) last posted its quarterly earnings results on Wednesday, April 29th. The company reported GBX (2.78) earnings per share for the quarter. Futura Medical had a negative return on equity of 310.00% and a negative net margin of 534.62%.The business had revenue of GBX 170 million for the quarter. As a group, sell-side analysts forecast that Futura Medical plc will post 2.8486672 EPS for the current year.

Futura Medical Company Profile

Futura Medical plc (AIM: FUM) is the developer of innovative sexual health products, including lead product Eroxon® and products WSD4000 and Eroxon® Intense. Our core strength lies in our research, development and commercialisation of topically delivered gel formulations in sexual health products.

Sexual health issues are prevalent in both men and women. ED impacts 1 in 5 men globally across all adult age brackets, with approximately half of all men over 40 experiencing ED and 25% of all new diagnoses being in men under 40.